These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9046322)

  • 41. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for non-septic ICU patients: a rebuttal.
    James M; Joubert I; Michell WL; Nicol A; Navsaria P; Gillespie R
    Crit Care; 2015 Dec; 19():444. PubMed ID: 26699365
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of hydroxyethyl starch in critically ill patients.
    Brunkhorst FM; Schortgen F
    Br J Anaesth; 2007 Jun; 98(6):842-3; author reply 843-4. PubMed ID: 17519265
    [No Abstract]   [Full Text] [Related]  

  • 43. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch.
    Wiedermann CJ
    Intensive Care Med; 2004 Mar; 30(3):519-20; author reply 521. PubMed ID: 14727021
    [No Abstract]   [Full Text] [Related]  

  • 44. Is Hydroxyethyl Starch 130/0.4 Safe for the Kidney in Noncardiac Surgical Patients?
    Xue FS; Cui XL; Wang SY
    Anesthesiology; 2015 Aug; 123(2):481-2. PubMed ID: 26196876
    [No Abstract]   [Full Text] [Related]  

  • 45. Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?
    Mills GH
    Br J Anaesth; 2007 Feb; 98(2):157-9. PubMed ID: 17251208
    [No Abstract]   [Full Text] [Related]  

  • 46. No coagulation disorders under high-dose volume therapy with low-molecular-weight hydroxyethyl starch.
    Stoll M; Treib J; Schenk JF; Windisch F; Haass A; Wenzel E; Schimrigk K
    Haemostasis; 1997; 27(5):251-8. PubMed ID: 9690484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydroxyethyl starch-induced postoperative bleeding in cardiac surgery patients: more trials needed?
    Wilkes MM; Navickis RJ
    Chest; 2004 Jul; 126(1):311-2; author reply 312. PubMed ID: 15249479
    [No Abstract]   [Full Text] [Related]  

  • 48. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.
    Langeron O; Doelberg M; Ang ET; Bonnet F; Capdevila X; Coriat P
    Anesth Analg; 2001 Apr; 92(4):855-62. PubMed ID: 11273914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxyethyl starch: here today, gone tomorrow.
    Nolan JP; Mythen MG
    Br J Anaesth; 2013 Sep; 111(3):321-4. PubMed ID: 23946354
    [No Abstract]   [Full Text] [Related]  

  • 50. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
    Waitzinger J; Bepperling F; Pabst G; Opitz J
    Drugs R D; 2003; 4(3):149-57. PubMed ID: 12757400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.
    Laake JH; Tønnessen TI; Chew MS; Lipcsey M; Hjelmqvist H; Wilkman E; Pettilä V; Hoffmann-Petersen J; Møller MH;
    Acta Anaesthesiol Scand; 2018 Jul; 62(6):874-875. PubMed ID: 29658984
    [No Abstract]   [Full Text] [Related]  

  • 52. Hydroxyethyl starch: putting patient safety first.
    Bion J; Bellomo R; Myburgh J; Perner A; Reinhart K; Finfer S
    Intensive Care Med; 2014 Feb; 40(2):256-259. PubMed ID: 24352482
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hydroxyethyl starch: Statement of the Presidents of DGAI and the BDA and the President of the DAAF].
    Werner C; Geldner G; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):437. PubMed ID: 23929160
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hydroxyethyl starch for volume replacement therapy - a swan song?].
    Ittner KP
    Dtsch Med Wochenschr; 2013 Nov; 138(48):2450. PubMed ID: 24254341
    [No Abstract]   [Full Text] [Related]  

  • 55. Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines.
    Biancofiore G; Vaglio S; Liumbruno GM
    Blood Transfus; 2016 May; 14(2):195-6. PubMed ID: 27177414
    [No Abstract]   [Full Text] [Related]  

  • 56. Update: New England Journal of Medicine publishes correction to 2012 CHEST trial of hydroxyethyl starch versus colloids.
    Doshi P
    BMJ; 2016 Mar; 352():i1571. PubMed ID: 27001086
    [No Abstract]   [Full Text] [Related]  

  • 57. Coagulation studies after transfusion of hydroxyethyl starch protected frozen blood in primates.
    Weatherbee L; Spencer HH; Knorpp CT; Lindenauer SM; Gikas PW; Thompson NW
    Transfusion; 1974; 14(2):109-15. PubMed ID: 12731582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does albumin interfere with coagulation-related outcomes when comparing colloids in cardiac surgery?
    Durukan AB; Tavlasoglu M; Gurbuz HA
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):309-10. PubMed ID: 23244263
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of hetastarch for volume expansion.
    Iacono RP; Linford J
    J Neurosurg; 1987 Apr; 66(4):635-7. PubMed ID: 2435868
    [No Abstract]   [Full Text] [Related]  

  • 60. Acute kidney injury in cardiac surgery patients receiving hydroxyethyl starch solutions.
    Bayer O; Reinhart K
    Crit Care; 2015 May; 19(1):209. PubMed ID: 25940561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.